Identification of Three Prognosis-Related Differentially Expressed LncRNAs Driven by Copy Number Variation in Thyroid Cancer

Overview

Journal J Immunol Res

Publisher Wiley

Specialty Allergy & Immunology

Date 2022 Jun 1

PMID 35642209

Authors

Jinyi Tian

Bin Luo

Affiliations

Soon will be listed here.

Abstract

Thyroid cancer as the malignant tumor with the highest incidence in the endocrine system also shows a fast growth and development. In this work, we developed a new method to identify copy number variation- (CNV-) driven differentially expressed lncRNAs in thyroid cancer for predicting cancer prognosis. The data of RNA sequencing, CNV, methylation, mutation, and clinical details of thyroid cancer were obtained from the Cancer Genome Atlas database (TCGA). Molecular subtypes were clustered by iClusterPlus. Weighted gene co-expression network analysis (WGCNA) was employed to show co-expression modules. DEseq2 was conducted to identify protein coding genes (PCGs) and differentially expressed lncRNAs. CNV was detected using GISTIC 2.0. Three molecular subtypes were identified, and 68 differentially expressed lncRNAs (DElncRNAs) related to cancer were found among different molecular subtypes. CNV of FOXD2-AS1, FAM181A-AS1, and RNF157-AS1 was associated with overall survival and was involved in cancer-related pathways. These three DElncRNAs discovered based on CNV could serve as prognostic biomarkers to predict prognosis for thyroid cancer and new targets to explore molecular drugs.

Citing Articles

Potential functions and mechanisms of lysine crotonylation modification (Kcr) in tumorigenesis and lymphatic metastasis of papillary thyroid cancer (PTC).

Li Z, Li J, Li F, Han L, Sui C, Zhou L J Transl Med. 2024; 22(1):874.

PMID: 39342359 PMC: 11439252. DOI: 10.1186/s12967-024-05651-4.

Multi-omics approach for identifying CNV-associated lncRNA signatures with prognostic value in prostate cancer.

Tyagi N, Roy S, Vengadesan K, Gupta D Noncoding RNA Res. 2023; 9(1):66-75.

PMID: 38075203 PMC: 10700122. DOI: 10.1016/j.ncrna.2023.10.001.

S100 proteins in head and neck squamous cell carcinoma (Review).

Hu Y, Han Y, He M, Zhang Y, Zou X Oncol Lett. 2023; 26(2):362.

PMID: 37545618 PMC: 10398633. DOI: 10.3892/ol.2023.13948.

The Biological Roles and Molecular Mechanisms of Long Non-Coding RNA MEG3 in the Hallmarks of Cancer.

Zhang L, Zhao F, Li W, Song G, Kasim V, Wu S Cancers (Basel). 2022; 14(24).

PMID: 36551518 PMC: 9775699. DOI: 10.3390/cancers14246032.

Decreased Expression of a Novel lncRNA FAM181A-AS1 is Associated with Poor Prognosis and Immune Infiltration in Lung Adenocarcinoma.

Liang W, Lu Y, Pan X, Zeng Y, Zheng W, Li Y Pharmgenomics Pers Med. 2022; 15:985-998.

PMID: 36482943 PMC: 9724578. DOI: 10.2147/PGPM.S384901.

References

Xu M, Guo X, Wang R, Zhang Z, Jia Y, Sun X . Long non-coding RNA HANR as a biomarker for the diagnosis and prognosis of colorectal cancer. Medicine (Baltimore). 2020; 99(7):e19066. PMC: 7035088. DOI: 10.1097/MD.0000000000019066. View

Jiang W, Xia J, Xie S, Zou R, Pan S, Wang Z . Long non-coding RNAs as a determinant of cancer drug resistance: Towards the overcoming of chemoresistance via modulation of lncRNAs. Drug Resist Updat. 2020; 50:100683. DOI: 10.1016/j.drup.2020.100683. View

Mermel C, Schumacher S, Hill B, Meyerson M, Beroukhim R, Getz G . GISTIC2.0 facilitates sensitive and confident localization of the targets of focal somatic copy-number alteration in human cancers. Genome Biol. 2011; 12(4):R41. PMC: 3218867. DOI: 10.1186/gb-2011-12-4-r41. View

Soong D, Stratford J, Avet-Loiseau H, Bahlis N, Davies F, Dispenzieri A . CNV Radar: an improved method for somatic copy number alteration characterization in oncology. BMC Bioinformatics. 2020; 21(1):98. PMC: 7060549. DOI: 10.1186/s12859-020-3397-x. View

Yu G, Wang L, Han Y, He Q . clusterProfiler: an R package for comparing biological themes among gene clusters. OMICS. 2012; 16(5):284-7. PMC: 3339379. DOI: 10.1089/omi.2011.0118. View

Li H, Han Q, Chen Y, Chen X, Ma R, Chang Q . Upregulation of the long non-coding RNA FOXD2-AS1 is correlated with tumor progression and metastasis in papillary thyroid cancer. Am J Transl Res. 2019; 11(9):5457-5471. PMC: 6789238. View

Verhaegh G, Verkleij L, Vermeulen S, den Heijer M, Witjes J, Kiemeney L . Polymorphisms in the H19 gene and the risk of bladder cancer. Eur Urol. 2008; 54(5):1118-26. DOI: 10.1016/j.eururo.2008.01.060. View

Panebianco F, Nikitski A, Nikiforova M, Nikiforov Y . Spectrum of TERT promoter mutations and mechanisms of activation in thyroid cancer. Cancer Med. 2019; 8(13):5831-5839. PMC: 6792496. DOI: 10.1002/cam4.2467. View

Robin X, Turck N, Hainard A, Tiberti N, Lisacek F, Sanchez J . pROC: an open-source package for R and S+ to analyze and compare ROC curves. BMC Bioinformatics. 2011; 12:77. PMC: 3068975. DOI: 10.1186/1471-2105-12-77. View

10.

Sherman S . Thyroid carcinoma. Lancet. 2003; 361(9356):501-11. DOI: 10.1016/s0140-6736(03)12488-9. View

11.

Langfelder P, Horvath S . WGCNA: an R package for weighted correlation network analysis. BMC Bioinformatics. 2008; 9:559. PMC: 2631488. DOI: 10.1186/1471-2105-9-559. View

12.

Bray F, Ferlay J, Soerjomataram I, Siegel R, Torre L, Jemal A . Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018; 68(6):394-424. DOI: 10.3322/caac.21492. View

13.

Subramanian A, Kuehn H, Gould J, Tamayo P, Mesirov J . GSEA-P: a desktop application for Gene Set Enrichment Analysis. Bioinformatics. 2007; 23(23):3251-3. DOI: 10.1093/bioinformatics/btm369. View

14.

Zheng M, Hu Y, Gou R, Nie X, Li X, Liu J . Identification three LncRNA prognostic signature of ovarian cancer based on genome-wide copy number variation. Biomed Pharmacother. 2020; 124:109810. DOI: 10.1016/j.biopha.2019.109810. View

15.

Redon R, Ishikawa S, Fitch K, Feuk L, Perry G, Andrews T . Global variation in copy number in the human genome. Nature. 2006; 444(7118):444-54. PMC: 2669898. DOI: 10.1038/nature05329. View

16.

Liu L, Yang J, Zhu X, Li D, Lv Z, Zhang X . Long noncoding RNA H19 competitively binds miR-17-5p to regulate YES1 expression in thyroid cancer. FEBS J. 2016; 283(12):2326-39. DOI: 10.1111/febs.13741. View

17.

Piao H, Guo S, Wang Y, Zhang J . Exosomal Long Non-Coding RNA CEBPA-AS1 Inhibits Tumor Apoptosis and Functions as a Non-Invasive Biomarker for Diagnosis of Gastric Cancer. Onco Targets Ther. 2020; 13:1365-1374. PMC: 7034294. DOI: 10.2147/OTT.S238706. View

18.

Li Q, Chen W, Luo R, Zhang Z, Song M, Chen W . Upregulation of OIP5-AS1 Predicts Poor Prognosis and Contributes to Thyroid Cancer Cell Proliferation and Migration. Mol Ther Nucleic Acids. 2020; 20:279-291. PMC: 7078457. DOI: 10.1016/j.omtn.2019.11.036. View

19.

Cibulskis K, Lawrence M, Carter S, Sivachenko A, Jaffe D, Sougnez C . Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples. Nat Biotechnol. 2013; 31(3):213-9. PMC: 3833702. DOI: 10.1038/nbt.2514. View

20.

Love M, Huber W, Anders S . Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 2014; 15(12):550. PMC: 4302049. DOI: 10.1186/s13059-014-0550-8. View